[EN] QUINAZOLINEDIONES AS TANKYRASE INHIBITORS<br/>[FR] INHIBITEURS DE TANKYRASE DE TYPE QUINAZOLINEDIONES
申请人:GLAXOSMITHKLINE LLC
公开号:WO2013177349A2
公开(公告)日:2013-11-28
This invention relates to the use of quinazolinediones for the modulation, notably the inhibition of the activity of tankyrases (TNKS1 and TNKS2). Suitably, the present invention relates to the use of quinazolinediones in the treatment of cancer, fibrosis and other hyperproliferative diseases through this mechanism.